Clinical Trial Update: APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

APN401 was evaluated in a Phase 1 trial for patients with recurrent or metastatic pancreatic cancer, colorectal cancer, and unresectable solid tumors including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• APN401

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Solid Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2024-10-10